Harrow Stock

Harrow Gross Margin

The Gross Margin of Harrow (HROW) as of Aug 9, 2026 is 75.05 %. In the previous year, Gross Margin was 75.33 % — a change of -0.37% (lower).

Gross Margin

75.05 %

YoY

-0.37%

Last updated:

Gross Margin of Harrow is 2026 75.05 % . Gross Margin of Harrow was 2025 75.33 % . It decreases by -0.37% lower compared to the previous year.

For Harrow, the gross margin of 75.1% is broadly stable versus 74.9% a few years ago.

Access this data via the Eulerpool API

Harrow Stock analysis

What does Harrow do? Harrow Health Inc is a healthcare company based in San Diego that specializes in the development, manufacturing, and marketing of innovative medical products. The company was founded in 2012 as Imprimis Pharmaceuticals and has since become a significant player in the healthcare market. Harrow is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Harrow stock

Gross Margin of Harrow is 75.05 % in 2026.

Gross Margin of Harrow changed from 75.33 % to 75.05 %, representing a -0.37% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Gross Margin Harrow since 2006 – with annual values, charts, and detailed analysis.

Gross Margin measures the percentage of revenue remaining after COGS. Higher gross margins indicate more efficient production and stronger pricing power.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Gross Margin's Harrow with sector peers and the industry average to assess whether it is attractive.

To evaluate Gross Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Gross Margin.

Access this data via the Eulerpool API

Margins — Harrow

All Key Metrics — Harrow